Treatment of Enterococcus Faecalis Biofilm Infections

Introduction to Treatment Approaches

• The American Heart Association recommends a combination of ampicillin-ceftriaxone for the treatment of Enterococcus faecalis biofilm infections, which effectively targets biofilm-embedded bacteria through saturation of different penicillin-binding proteins 1, 2

First-line Treatment Options

• The Infectious Diseases Society of America recommends a double β-lactam regimen (ampicillin-ceftriaxone) as the first-line treatment for E. faecalis biofilms, including those with high-level aminoglycoside resistance 1, 2
• The European Society of Clinical Microbiology and Infectious Diseases suggests that ampicillin plus aminoglycoside (gentamicin) can be considered for susceptible strains, with short-course gentamicin therapy (2 weeks) and β-lactam (4-6 weeks) showing similar efficacy to longer aminoglycoside courses with reduced nephrotoxicity 2

Treatment Considerations Based on Infection Site

• For endocarditis, the American College of Cardiology recommends a double β-lactam regimen (ampicillin-ceftriaxone) for 4-6 weeks, with device removal (valve replacement) necessary in severe cases 1, 2
• For catheter-related infections, the Society for Healthcare Epidemiology of America suggests catheter removal as essential when possible, with antimicrobial lock therapy considered for long-term catheters that cannot be removed 3

General Treatment Considerations

• Prolonged antibiotic therapy (>10 days) increases the risk of enterococcal colonization and potential superinfection with resistant strains, according to the Infectious Diseases Society of America 4